Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2005
04/14/2005WO2005033065A1 Novel amidine compounds for treating microbial infections
04/14/2005WO2005032547A1 Bicyclo`3.1.1!heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors
04/14/2005WO2005032541A1 Substituted heterocyclic mercaptosulfide inhibitors
04/14/2005WO2005032493A2 Amide compounds as ion channel ligands and uses thereof
04/14/2005WO2005032490A2 Cyclic diamines and derivatives as factor xa inhibitors
04/14/2005WO2005021510A3 Benzimidazole c-2 heterocycles as kinase inhibitors
04/14/2005WO2005016883A3 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
04/14/2005WO2005002503A3 Asymmetric benzimidazoles and related compounds as potassium channel modulators
04/14/2005US20050080258 Kinase inhibitors; autoimmune disease; antiinflammatory agents
04/14/2005US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others
04/14/2005US20050080110 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group
04/14/2005US20050080108 such as (S)-1-ethyl-5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid-[2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]amide; for treatment of obesity and lipid disorders; diabetes
04/14/2005US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
04/14/2005US20050080101 N-[4-(pyrazolyl)-pyrimidin-2-yl]-N-phenyl-amine derivatives
04/14/2005US20050080096 Condensed heterocyclic compounds
04/14/2005US20050080091 Capped pyrazinoylguanidine sodium channel blockers
04/14/2005US20050080087 For treatment of metabolic disorders, eating disorders, appetitive disorders, psychiatric disorders, memory impairment, Parkinson's disease, Alzheimer's disease, substance abuse, leukocyte activation-associated disorders, and inflammatory diseases
04/14/2005US20050080017 Viricide against hepatitis virus; pyrrole derivatives as, for example, 3-acetyl-4,5-dimethyl-2-pyrrole carboxylic acid
04/14/2005CA2541299A1 Amide compounds as ion channel ligands and uses thereof
04/14/2005CA2540640A1 Vanilloid receptor ligands and their use in treatments
04/14/2005CA2540638A1 Quinoxaline compounds
04/14/2005CA2540517A1 Process for upgrading naphtha
04/14/2005CA2540502A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
04/14/2005CA2539339A1 Compounds and compositions as protein kinase inhibitors
04/14/2005CA2537791A1 Novel amidine compounds for treating microbial infections
04/13/2005EP1522540A1 Azaarene derivatives
04/13/2005EP1521755A1 Novel diketopyrrolopyrrole pigments
04/13/2005EP1521749A1 PHENYL-(4-(3-PHENYL-1H-PYRAZOL-4-YL)-PYRIMIDIN-2-Yl)-AMINE DERIVATIVES
04/13/2005EP1521747A2 Receptor-type kinase modulators and methods of use
04/13/2005EP1521733A1 Modulators of the glucocorticoid receptor
04/13/2005EP0880507B1 Quinazoline derivatives as antitumor agents
04/13/2005CN1606554A Beta-lactamyl vasopressin v1aantagonists
04/13/2005CN1606553A Oxytocin agonistenoxytocin agonisten
04/13/2005CN1606547A 5-phenylpyrimidines, fungicide compositions comprising the same, method for producing and use thereof
04/13/2005CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists
04/13/2005CN1606444A Inhibitors of human phosphatidyl-inositol 3-kinase delta
04/13/2005CN1606443A Substituted diketopiperazines as oxytocin antagonists
04/13/2005CN1606439A Cis-imidazolines
04/13/2005CN1605586A Alpha-substituted 2-methyl-5-nitroimidazole-1-ethanol derivatives
04/13/2005CN1196685C Pyrimidine derivatives
04/13/2005CN1196497C Near infrared fluorescent contrast agent and fluorescence imaging
04/12/2005US6878743 Controlling apoptosis; central nervous system disorders
04/12/2005US6878739 Composition for treating or preventing glomerulopathy
04/12/2005US6878736 Histamine H3 receptor ligands
04/12/2005US6878735 Multi-substituted imidazolines and method of use thereof
04/12/2005US6878734 Gastrin and cholecystokinin receptor ligands(II)
04/12/2005US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough
04/12/2005US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals
04/12/2005US6878717 HIV replication inhibiting pyrimidines
04/12/2005US6878709 Treating acute and chronic inflammatory disorders and cancer.
04/12/2005US6878704 Heterocyclic mutilin esters and their use as antibacterials
04/12/2005US6878697 Containing one or more phosphorus-containing moieties; treating bone disorders
04/12/2005CA2122571C Adhesion receptor antagonists
04/12/2005CA2081836C Aromatic amidine derivatives and salts thereof
04/07/2005WO2005030796A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
04/07/2005WO2005030794A2 Hemiasterlin derivatives and uses thereof
04/07/2005WO2005030762A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030761A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030758A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof
04/07/2005WO2005030757A1 Quinazoline derivatives
04/07/2005WO2005030756A1 Substituted pyrrole-indoles as inhibitors of pai-1
04/07/2005WO2005030735A1 Triazines derivatives as cell adhesion inhibitors
04/07/2005WO2005030717A1 Substituted indole acid derivatives and their use as pai-1 inhibitors
04/07/2005WO2005030715A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors
04/07/2005WO2005030702A1 Biphenyloxy-acids
04/07/2005WO2005030216A1 5-arylpyrimidines as anticancer agents
04/07/2005WO2005030206A1 Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity
04/07/2005WO2005030131A2 Bis-quinazoline compounds for the treatment of bacterial infections
04/07/2005WO2005016918A3 Heterocyclic n-aryl carboxamides as cytokine inhibitors
04/07/2005WO2005012256A8 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
04/07/2005WO2005009975A3 Benzimidazole derivatives as mek inhibitors
04/07/2005WO2005007647A9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/07/2005WO2004112719A3 Chemical compounds
04/07/2005WO2004112709A3 Inhibitors of cathepsin s
04/07/2005WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds
04/07/2005WO2004014871A8 Vanilloid receptor ligands and their use in treatments
04/07/2005US20050075507 1,2,4-Triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
04/07/2005US20050075364 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS
04/07/2005US20050075357 5-arylpyrimidines as anticancer agents
04/07/2005US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS
04/07/2005US20050075348 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
04/07/2005US20050075347 For the prevention and/or therapy of ischaemia and reperfusion damage
04/07/2005US20050075334 Novel compounds
04/07/2005US20050075333 Substituted quinazolines and pyrimidinopyridines useful for the treatment of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes; compounds modulate the expression and/or function of a chemokine receptor
04/07/2005US20050075325 Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
04/07/2005CA2744997A1 C-met modulators and method of use
04/07/2005CA2540031A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
04/07/2005CA2540008A1 Quinazoline derivatives
04/07/2005CA2539823A1 Hemiasterlin derivatives and uses thereof
04/07/2005CA2539250A1 Biphenyloxy-acids
04/07/2005CA2539235A1 5-arylpyrimidines as anticancer agents
04/07/2005CA2538703A1 Substituted indole acid derivatives and their use as pai-1 inhibitors
04/07/2005CA2538355A1 Substituted pyrrole-indoles as inhibitors of pai-1
04/07/2005CA2538263A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors
04/06/2005EP1521107A1 Filters for electronic displays
04/06/2005EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers
04/06/2005EP1520450A1 Electroluminescent device
04/06/2005EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions
04/06/2005EP1520305A2 Charge transport compositions and electronic devices made with such compositions
04/06/2005EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives
1 ... 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 ... 626